Global Anxiety Disorders Industry Size And Forecast Report Up To 2015: Radiant Insights, Inc

Anxiety Disorders Industry Share and Size, Trends
and Growth, Analysis and Pipeline Review, H2
2015
Anxiety Disorders - Pipeline Review, H2 2015
Summary
Global Markets Direct's, 'Anxiety Disorders - Pipeline Review, H2 2015', provides an overview of the
Anxiety Disorders's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Anxiety Disorders,
complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in the therapeutic development for Anxiety
Disorders and special features on late-stage and discontinued projects.
Browse Full Report With TOC @ http://www.radiantinsights.com/research/anxiety-disorderspipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and industry-specific third party sources, put
together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic
updation following a stringent set of processes that ensures that all the profiles are updated with the latest
set of information. Additionally, processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent developments are captured on a real time
basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Scope
- The report provides a snapshot of the global therapeutic landscape of Anxiety Disorders
- The report reviews key pipeline products under drug profile section which includes, product description,
MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Anxiety Disorders and
enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Anxiety Disorders products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Anxiety Disorders pipeline on the basis of target, MoA, route of administration and
molecule type
- Latest news and deals relating related to pipeline products
Reasons to Buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective
R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Anxiety
Disorders
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Anxiety Disorders pipeline depth and
focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that
drove them from pipeline
Buy a Sample copy of This Report: http://www.radiantinsights.com/checkout/145810
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Anxiety Disorders Overview 11
Therapeutics Development 12
Pipeline Products for Anxiety Disorders - Overview 12
Pipeline Products for Anxiety Disorders - Comparative Analysis 13
Anxiety Disorders - Therapeutics under Development by Companies 14
Anxiety Disorders - Therapeutics under Investigation by Universities/Institutes 19
Anxiety Disorders - Pipeline Products Glance 20
Late Stage Products 20
Browse Full Report With TOC @ http://www.radiantinsights.com/research/anxiety-disorderspipeline-review-h2-2015
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over extensive database of
reports, our experienced research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]